Investing in Marijuana stocks is gaining popularity all over the world and there is a good reason for it. With the fast expansion of legalization globally and especially in the United States and Canada, the market is still growing. In this article, we will discuss Tilray stock, one of the best performing marijuana stocks at this moment.
Tilray General Information
Tilray has 912.000 square feet of greenhouse for the cultivation of medical marijuana. Divided over four facilities Tilray sells medical Cannabis products in 11 countries based in Latin America, Europe, Africa, Australia, and New-Zeeland. Their products exist of cannabis oils and dried flower divided into THC-dominant, CBD-dominant, and THC/CBD balanced products.
Tilray Stock Price Today
Tilray Stock Forecast & Predictions
In October 2018 Tilray made a deal with with the Ontario Cannabis Retail Corporation. As a new partner of the OCS Tilray is going to supply the province of Ontario with a variety of different Cannabis products. Ontario is the most densely populated province of Canada with 12.6 million inhabitants. Tilray will be active in this province through the recently founded company called High Park. With this new company, they have obtained a 662.000 square foot growing facility.
High Park was founded with the purpose of selling and distributing cannabis products and brands for the recreational market. With this new deal, Tilray is going to offer brands like Marley Natural, Irisa, and Canaca. While Marley Natural sells different kinds of pre-rolls Irisa is a Cannabis wellness brand offering products like massage oil and sublingual drops. For the people that vape or just want dried flower Canaca will offer Canadians finest buds.
To expand the supply of Cannabis products Tilray has signed a $100 million revenue-sharing deal with Authentic Brands Group in January of 2019. Authentic Brands Group is a marketing, entertainment, and brand development company. ABG was founded in 2010 and now has its headquarters in New York City. At this moment they manage a portfolio of more than 50 different brands like Tap out, Juicy Couture and more. With this new-made deal Tilray and ABG, will work together to market and distribute Cannabis products. Tilray paid ABG $100 million and up to $250 million in cash and stock. In exchange for this, Tilray will receive 49% of the revenue that comes from the Cannabis products sold by ABG.
Since March of 2018 Tilray has started working together with Sandoz AG for the supply of medical marijuana products in Canada. Sandoz AG is a big pharma company with over 130.000 employees and has around 1 billion patients in 180 countries all over the world. In December of 2018 Tilray announced that they will expand the partnership even more. Signing a global framework agreement Tilray will work together with Sandoz AG in order to increase the availability of high-grade medical marijuana products all over the world.
Sandoz AG will on his turn maximize the commercialization and supply of non-combustible and non-smokeable marijuana products offered by Tilray. In 2017 alone Sandoz AG has spent 9 billion dollars on research and development of new products. In the future, it’s highly likable that Tilray and Sandoz AG will work together in the development of new medical cannabis products.
Tilray Stock Latest News
Now that you are completely up to date with regard to Tilray stock you may decide to buy Tilray stocks. Never forget to not use money that you can’t afford to lose and have look at our other stock articles as well!
Hey guys! My name is Anthony Ellsworth and I am passionate about nature and everything it has to offer. Since I was still a kid I always felt a strong connection with nature and the urge to explore. This passion has led me to study biology later on in life and lots of exploring. Now, together with my beautiful wife Jennifer, it has become our goal to share all the knowledge that we have built up together through the years. If you have any questions or what so ever feel free to ask them anytime!